Why is Boston Bio falling/rising?

As of 14-Aug, Boston Bio Systems Ltd's stock price is currently at 7.90, reflecting a decrease of 0.09, or 1.13%. The stock has underperformed its sector by 3.61% today and has experienced a trend reversal after two consecutive days of gains. Although the stock's performance over the past week shows a modest increase of 0.77%, it has outperformed the benchmark Sensex, which has seen a slight decline of 0.03%. However, the stock's delivery volume has significantly decreased by 54.05% compared to the five-day average, indicating a drop in investor participation. Additionally, while the stock is trading above its 5-day, 20-day, and 50-day moving averages, it remains below the 100-day and 200-day moving averages, suggesting mixed momentum in its recent price action.
In the broader market context, the medical equipment sector has gained by 2.64%, contrasting with Boston Bio's decline, which highlights the company's struggle to keep pace with sector performance. The stock's short-term return of 0.77% over the past week is notably better than the Sensex's performance, which has declined. However, the overall negative sentiment surrounding the stock, driven by falling investor participation and a recent trend reversal, indicates that despite some positive returns over the past month, the current market dynamics are weighing on Boston Bio's stock price.